BRENNER RANDALL B. (Chief Development & Regulatory) received a stock award from PARATEK PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 10/27/2022ACC: 0000904454-22-000506
Officer· Chief Development & Regulatory
Since Sep 2019
+8.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
8.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+8.50K
Price / share
—
Trade value
—
% of position
2.4%
10/25/2022
349.15K→357.65K
Total
Net shares
+8.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/25/2022 | A · Award | +8.50K | — | — | 2.4% | 349.15K | 357.65K |
| Total | +8.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported